SRDX SURMODICS INC

Nasdaq surmodics.com


$ 28.23 $ 0.18 (0.64 %)    

Wednesday, 22-Oct-2025 15:59:54 EDT
QQQ $ 604.27 $ -5.89 (-0.96 %)
DIA $ 464.98 $ -3.44 (-0.73 %)
SPY $ 666.76 $ -3.49 (-0.52 %)
TLT $ 92.19 $ 0.06 (0.07 %)
GLD $ 376.01 $ 0.04 (0.01 %)
$ 28.28
$ 28.25
$ 26.00 x 1
$ 38.00 x 50
$ 27.89 - $ 28.46
$ 26.00 - $ 40.39
105,385
na
404.34M
$ 0.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
2 04-30-2025 03-31-2025 10-Q
3 01-30-2025 12-31-2024 10-Q
4 11-20-2024 09-30-2024 10-K
5 07-31-2024 06-30-2024 10-Q
6 05-01-2024 03-31-2024 10-Q
7 02-01-2024 12-31-2023 10-Q
8 08-02-2023 06-30-2023 10-Q
9 04-26-2023 03-31-2023 10-Q
10 02-06-2023 12-31-2022 10-Q
11 11-23-2022 09-30-2022 10-K
12 07-27-2022 06-30-2022 10-Q
13 04-27-2022 03-31-2022 10-Q
14 02-04-2022 12-31-2021 10-Q
15 11-24-2021 09-30-2021 10-K
16 08-04-2021 06-30-2021 10-Q
17 04-28-2021 03-31-2021 10-Q
18 02-09-2021 12-31-2020 10-Q
19 12-02-2020 09-30-2020 10-K
20 08-05-2020 06-30-2020 10-Q
21 04-30-2020 03-31-2020 10-Q
22 02-07-2020 12-31-2019 10-Q
23 12-03-2019 09-30-2019 10-K
24 08-01-2019 06-30-2019 10-Q
25 05-03-2019 03-31-2019 10-Q
26 02-01-2019 12-31-2018 10-Q
27 11-30-2018 09-30-2018 10-K
28 08-06-2018 06-30-2018 10-Q
29 05-04-2018 03-31-2018 10-Q
30 02-08-2018 12-31-2017 10-Q
31 12-01-2017 09-30-2017 10-K
32 08-03-2017 06-30-2017 10-Q
33 04-28-2017 03-31-2017 10-Q
34 02-03-2017 12-31-2016 10-Q
35 12-02-2016 09-30-2016 10-K
36 07-29-2016 06-30-2016 10-Q
37 05-10-2016 03-31-2016 10-Q
38 02-05-2016 12-31-2015 10-Q
39 12-04-2015 09-30-2015 10-K
40 08-06-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barrington-research-reiterates-market-perform-on-surmodicsto-market-perform

Barrington Research analyst Michael Petusky reiterates Surmodics (NASDAQ:SRDX) from Market Perform to Market Perform.

 surmodics-raises-fy2025-adj-eps-guidance-from-062-042-to-035-020-vs-055-est-raises-fy2025-sales-guidance-from-114000m-117000m-to-116500m-118500m-vs-115686m-est

Fiscal Year 2025 Financial GuidanceSurmodics is increasing its fiscal 2025 total revenue to a range of $116.5 million to $118.5...

 needham-reiterates-hold-on-surmodicsto-hold

Needham analyst Mike Matson reiterates Surmodics (NASDAQ:SRDX) from Hold to Hold.

 surmodics-sees-fy2025-gaap-eps-160-140-vs-061-est

Surmodics (NASDAQ:SRDX) is looking for FY2025 GAAP EPS of $(1.60)-$(1.40) vs $(0.61) analyst estimate..

 surmodics-sees-fy2025-adj-eps-062-042-vs-037-est-sees-sales-114000m-117000m-vs-12727m-est

Surmodics (NASDAQ:SRDX) is looking for FY2025 Adj EPS of $(0.62)-$(0.42) vs $(0.37) analyst estimate. sees sales of $114.000 mi...

 surmodics-q2-adj-eps-013-misses-011-estimate-sales-2809m-miss-3223m-estimate

Surmodics (NASDAQ:SRDX) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) b...

 deal-dispatch-us-ma-is-quiet-but-abroad-volume-is-spiking

BofA predicted a friendlier FTC under Trump. They were wrong. Deal activity was virtually flat in Q1. But it's a U.S. problem.

 lake-street-upgrades-surmodics-to-buy-maintains-price-target-to-43

Lake Street analyst Brooks O'Neil upgrades Surmodics (NASDAQ:SRDX) from Hold to Buy and maintains the price target from ...

 deal-dispatch-clock-ticks-on-tiktok-raizen-explores-asset-sale-investors-urge-walgreens-to-go-private

This week's Deal Dispatch has updates on Raizen, Walgreens, TikTok and Canoo. Plus: the FTC is blocking mergers like it'...

 why-surmodics-stock-is-falling-on-friday

Surmodics stock drops 4.76% in premarket trading following news that the FTC will challenge its proposed acquisition by GTCR.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION